The completion of the funding round follows Newronika’s recent receival of an IDE from the FDA for the Parkinson’s therapy ...

Newronika, a global leader in advanced deep brain stimulation, is pleased to announce the successful closing of its €13.6 ...

Newronika announced today that it closed a €13.6 million ($14.1 million) Series B round to support its deep brain stimulation ...

The trial will assess the efficacy and safety of the system in individuals with movement disorders such as Parkinson's ...

In the first episode of The Deep End Podcast, we meet Jon Nelson, who shares why he volunteered to get brain implants for his relentless depression.

Medicare covers deep brain stimulation (DBS) to treat Parkinson’s disease or essential tremor when a doctor deems it medically necessary and when a person meets the coverage criteria.

Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an ...

Unable to speak because of a brain disorder known as spasmodic dysphonia, Susan O'Sullivan signed up for a clinical trial, ...

Discover how groundbreaking brain stimulation technology is giving hope to individuals with paralysis Learn about the ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) ...

Newronika announced today that it received FDA investigational device exemption (IDE) for its deep brain stimulation (DBS) system.